| Identifying Current Practices and Areas for Improvement in Medication Management During Care Transition Through an Interprofessional Collaboration Framework | Journal of multidisciplinary healthcare |  | | 2025 | 7 | 40 |
|
| Population Pharmacokinetics of Trametinib and Impact of Nonadherence on Drug Exposure in Oncology Patients as Part of the Optimizing Oral Targeted Anticancer Therapies Study | Cancers | | | 2024 | 82 | 377 |
|
| Infant exposure to Fluvoxamine through placenta and human milk : a case series - A contribution from the ConcePTION project | Frontiers in psychiatry | | | 2023 | 88 | 103 |
|
| Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study | Cancers | | | 2023 | 184 | 112 |
|
| Interventions to Support Adherence to Oral Anticancer Therapies: Research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland | Supportive care in cancer | | | 2022 | 302 | 469 |
|
| Population pharmacokinetics of palbociclib and its correlation with clinical efficacy and safety in patients with advanced breast cancer | Pharmaceutics | | | 2022 | 139 | 247 |
|
| Optimizing oral targeted anticancer therapies study for patients with solid cancer: protocol for a randomized controlled medication adherence program along with systematic collection and modeling of pharmacokinetic and pharmacodynamic data | JMIR research protocols | | | 2021 | 243 | 358 |
|
| Population pharmacokinetics of erlotinib in patients with non-small cell lung cancer: Its application for individualized dosing regimens in older patients | Clinical Therapeutics |  | | 2020 | 387 | 1 |
|
| Therapeutic drug monitoring of targeted anticancer protein kinase inhibitors in routine clinical use: A critical review | Therapeutic Drug Monitoring | | | 2020 | 268 | 1 |
|
| Optimization of the potential therapeutic benefit of protein kinase inhibitors used in cancer | | | | 2019 | 704 | 12 |
|
| Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry | Journal of Chromatography. B | | | 2018 | 289 | 0 |
|
| Effect of adherence on pharmacokinetic/pharmacodynamic relationships of oral targeted anticancer drugs | Clinical Pharmacokinetics | | | 2018 | 307 | 0 |
|
| Caractérisation du profil pharmacocinétique du saquinavir chez des patients HIV positifs | | | | 2012 | 357 | 9 |
|
